Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -51.1% | -45.8% | 0 / 3 | -33.1% | +0.00 pp | -3.11 pp | -0.1% | 0.00 | — | 2,2 | −33,1% | 0,2 | −51,1% | — | 36.79 | — |
| Pts | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 3.600 (close price on 2026-10-13)EPS (TTM): −5,2
Financial charts
1.Revenue & growth
VND bn2,22Q2/26
1.Revenue & growth
VND bn2,22Q2/26
2.Profit & growth
VND bn0,19Q2/26
3.Profit mix (Penman)
VND bn-0,16Q2/26
4.Margins & cost structure
%1.6%Q2/26
5.Returns & cash cycle
% · days-0.6%Q2/26
6.Earnings quality & cash
VND bn-0,57Q2/26
7.Asset structure
VND bn105Q2/26
8.Funding & debt health
VND bn · times105Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %-851,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %16Q2/26
Adjusted EPS growth, latest quarter
-51.1%
Average adjusted EPS growth, 3 quarters
-64.7%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26